Misago® RX Self-expanding Peripheral Stent for Common and/or External Iliac Artery
NCT: NCT02793492 · COMPLETED
Brief Summary
This is a multi-center, single arm, non-randomized, prospective clinical study using the Misago® RX Self-expanding Peripheral Stent for treatment of de novo, restenotic, and/or occlusive lesion(s) of the common and/or external iliac artery.
Frequently Asked Questions
What is Misago® RX Self-expanding Peripheral Stent for Common and/or External Iliac Artery?
Misago® RX Self-expanding Peripheral Stent for Common and/or External Iliac Artery is a clinical trial registered under NCT02793492. Current status: COMPLETED.
What is the status of NCT02793492?
The current status of NCT02793492 (Misago® RX Self-expanding Peripheral Stent for Common and/or External Iliac Artery) is: COMPLETED.
When did Misago® RX Self-expanding Peripheral Stent for Common and/or External Iliac Artery start?
Misago® RX Self-expanding Peripheral Stent for Common and/or External Iliac Artery started on 2022-08-30.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.